As the con­sumer group splits away to­day, what will New GSK buy now?

3 years ago
Bioregnum
Pharma

As Big Phar­ma los­es in­ter­est in new an­tibi­otics, in­fec­tions are on­ly grow­ing stronger

3 years ago
R&D

Ex­clu­sive: Af­ter Covid piv­ot, biotech nabs funds to be first in the clin­ic with a non-hor­mon­al con­tra­cep­tive for men

3 years ago
Financing
Startups

Af­ter ini­tial com­mer­cial for­ay, Chi­na's CStone mulls sale — re­port

3 years ago
Deals

Pfiz­er sues Am­gen in ef­fort to in­val­i­date top can­cer drug patent

3 years ago
Pharma
Law

Manchin plays spoil­er again, but drug pric­ing re­forms re­main on the ta­ble

3 years ago
Pharma
Law

For­mer Spark ex­ec to lead a gene ther­a­py up­start of his own; Big Phar­ma mar­ket­ing vet named CEO of Swiss biotech

3 years ago
Peer Review

Drug short­ages re­main low in 2021 as FDA's pre­ven­tion ef­forts grow, re­port to Con­gress says

3 years ago
Pharma
FDA+

Can­cer Moon­shot moves for­ward with new 'Cancer Cab­i­net' and goals to re­duce can­cer

3 years ago
People
Pharma

Bay­er sells testos­terone treat­ment to Ger­man com­pa­ny for $500M

3 years ago
Deals
Pharma

Hap­pi­fy re­brands as Twill, weav­ing a new name for its ex­pand­ed dig­i­tal health and phar­ma busi­ness

3 years ago
Pharma
Marketing

#BIO22: De­cen­tral­ized tri­als

3 years ago

Phar­ma hir­ing con­tin­ues to grow in the US and tal­ent com­pe­ti­tion re­mains tight — re­port

3 years ago
People
Pharma

Ot­su­ka spon­sors Ken Burn­s' PBS youth and men­tal ill­ness doc­u­men­tary to dri­ve aware­ness and dis­pel stig­ma

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: FDA clears the way for more mon­key­pox vac­cines to be re­leased; Dis­cov­ery Life Sci­ence nets ...

3 years ago
Manufacturing

Te­va calls on SCO­TUS to take up bat­tle over 'skin­ny' gener­ic drug la­bels

3 years ago
Law

Texas biotech ex­pands R&D and man­u­fac­tur­ing ca­pa­bil­i­ties fol­low­ing Catal­ent part­ner­ship

3 years ago
R&D
Manufacturing

Eu­ro­pean Om­buds­man up­holds 'mal­ad­min­is­tra­tion' find­ing over miss­ing Pfiz­er CEO texts

3 years ago
Pharma

Ul­tragenyx sells $500M in roy­al­ty in­ter­est on rare dis­ease drug to Cana­di­an pen­sion plan

3 years ago
Deals
Pharma

Ther­a­vance, In­no­vi­va sell roy­al­ty rights on GSK's Trel­e­gy to Roy­al­ty Phar­ma for $1.3B up­front

3 years ago
Deals

Up­dat­ed: Con­tra­Fect to ter­mi­nate PhI­II MR­SA an­tibi­ot­ic tri­al — stock cap­sizes

3 years ago
R&D

Vir CSO de­part­ing next month to be Al­tos CMO; Bob Dug­gan’s Sum­mit Ther­a­peu­tics and the FDA try to make head­way

3 years ago
News Briefing

Il­lu­mi­na los­es chal­lenge to block EU an­titrust probe in­to $8B Grail buy­out

3 years ago
Deals
Pharma

Dark-horse ALS play­er touts open-la­bel sur­vival da­ta af­ter mid-stage flop, with plat­form study due soon

3 years ago
R&D
First page Previous page 493494495496497498499 Next page Last page
A service from the Financial Times